Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Gland Pharma Ltd. market cap is 284.68B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Gland Pharma Ltd. 52 week high is 2,194.00 as of April 27, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Gland Pharma Ltd. 52 week low is 861.00 as of April 27, 2024.
Gland Pharma Ltd. stock price today is 1,730.00.
Gland Pharma Ltd. stock price yesterday was 1,739.50.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Gland Pharma Ltd.’s P/E ratio is 43.21.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Gland Pharma Ltd. P/B ratio is 3.4269.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Gland Pharma Ltd.'s EBITDA is 22.57.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Gland Pharma Ltd. 50-day moving average is 1,790.67.
Gland Pharma Ltd. has 4,585 employees.